BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals

Reuters

Jan 15

BRIEF-<a href="https://laohu8.com/S/MAYND">Mayne Pharma</a> Receives Notice Of Appeal By Cosette Pharmaceuticals

Jan 15 (Reuters) - Mayne Pharma Group Ltd MYX.AX:

RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEAL
CONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEAL
GROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERS

Further company coverage: MYX.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2603567824"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603567824\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603567824?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-15 13:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603567824","market":"nz","top_or_hot":-1,"title":"BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/MAYND\">Mayne Pharma</a> Receives Notice Of Appeal By Cosette Pharmaceuticals</title></head><body><p><span>Jan 15 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/MYXDA.AU\">Mayne Pharma Group Ltd</a> <span>MYX.AX</span>:</p><ul><li><p>RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEAL</p></li><li><p>CONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEAL</p></li><li><p>GROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERS</p></li></ul><p>Further company coverage: <span>MYX.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette Pharmaceuticals\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-15 13:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/MAYND\">Mayne Pharma</a> Receives Notice Of Appeal By Cosette Pharmaceuticals</title></head><body><p><span>Jan 15 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/MYXDA.AU\">Mayne Pharma Group Ltd</a> <span>MYX.AX</span>:</p><ul><li><p>RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEAL</p></li><li><p>CONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEAL</p></li><li><p>GROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERS</p></li></ul><p>Further company coverage: <span>MYX.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF21V:1","article_id":"2603567824","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603567824","pubTimestamp":1768453957,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette PharmaceuticalsJan 15  - Mayne Pharma Group Ltd MYX.AX:RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEALCONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEALGROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERSFurther company coverage: MYX.AX ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","MYX.AU":"MAYNE PHARMA GROUP LTD","BK7096":"制药"},"translate_title":"简介-Mayne Pharma收到Cosette Pharmaceuticals的上诉通知","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MYX.AU":0.9},"content_text":"BRIEF-Mayne Pharma Receives Notice Of Appeal By Cosette PharmaceuticalsJan 15 (Reuters) - Mayne Pharma Group Ltd MYX.AX:RECEIVED A NOTICE OF APPEAL FILED BY COSETTE AND ITS BIDCO WITH SUPREME COURT OF NEW SOUTH WALES, COURT OF APPEALCONSIDERING NOTICE OF APPEAL AND INTENDS TO VIGOROUSLY DEFEND APPEALGROUNDS SET OUT IN NOTICE OF APPEAL SEEK TO CHALLENGE COURT'S FINDINGS REGARDING CO'S FY25 EBITDA, OTHERSFurther company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}